secwatch.observer — SEC 8-K summary
======================================

Issuer:     ATOSSA THERAPEUTICS, INC. (ATOS)
CIK:        0001488039
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001193125-25-220788
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Atossa Therapeutics posts updated corporate presentation; no specific financial details provided
--------------------------------------------------------------------------------

- Filed as Exhibit 99.1 on September 26, 2025, but presentation content not included in this filing text.
- No new financial figures, pipeline milestones, or guidance changes are extractable from the available text.
- Ticker ATOS; company is a clinical-stage biotech focused on breast cancer treatments.
- Investors would need to view the actual presentation to assess any material updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1488039/000119312525220788/0001193125-25-220788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1488039/000119312525220788/atos-20250926.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-220788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer